BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7747992)

  • 1. [The proliferative activity in epithelial hyperplasia of the breast].
    Kaneko M; Arihiro K; Fujii S; Inai K
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():46-51. PubMed ID: 7747992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells].
    Uporov AV; Tsyrlina EV; Pozharisskiĭ KM
    Vopr Onkol; 1998; 44(3):316-24. PubMed ID: 9695779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [AgNORs as an alternative to Ki67on paraffin-embedded material in breast carcinoma].
    Oddi G; Visca P; Parisi AM
    Pathologica; 1992; 84(1094):75-8. PubMed ID: 1300535
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ki 67 growth fraction in carcinomas and benign lesions of the breast].
    Kunz J; Schmidt A
    Zentralbl Pathol; 1993 Aug; 139(3):201-5. PubMed ID: 8218121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AgNOR quantification with special reference to staining patterns.
    Rüschoff J; Fauser G; Knüchel R; Hofstädter F
    Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
    Zhao T; Zhang YL; Li CD
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AgNOR, Ki-67 and PCNA expression in fibroepithelial tumours of the breast in correlation with morphological features.
    Barwijuk-Machała M; Musiatowicz B; Cylwik J; Reszeć J; Augustynowicz A
    Folia Morphol (Warsz); 2004 Feb; 63(1):133-5. PubMed ID: 15039920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised?
    Kunju LP; Kleer CG
    Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The overexpression of p53 and proliferative activity in precancerous and cancerous lesions of oral squamous epithelium.
    Ichikawa M; Ishii K; Nakajima T; Mogi K
    J Exp Clin Cancer Res; 1997 Jun; 16(2):141-6. PubMed ID: 9261738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different proliferative patterns characterize different preinvasive breast lesions.
    Viacava P; Naccarato AG; Bevilacqua G
    J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of two AgNOR counts with Ki-67 labeling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma.
    Mourad WA; Sneige N; Katz RL; Ordóñez NG
    Diagn Cytopathol; 1994; 10(2):113-9. PubMed ID: 8187588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proliferative activity of ependymomas. (Quantitative analysis of the expression of Ki67 and AgNOR)].
    Ferraraccio F; Accardo M; Cuccurullo L
    Pathologica; 1995 Apr; 87(2):112-20. PubMed ID: 8532401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
    Gulbahar MY; Yuksel H; Guvenc T; Okut H
    Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas.
    Zoeller J; Flentje M; Sinn P; Born IA
    Anal Cell Pathol; 1994 Jul; 7(1):77-88. PubMed ID: 7981138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histochemical and histomorphometric studies on growth fractions in human breast carcinoma].
    Hahn J; Linhart W; Müller H; Renz S; Schneider M
    Verh Dtsch Ges Pathol; 1990; 74():262-7. PubMed ID: 1708598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications.
    Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W
    Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar organizer regions: a prognostic factor in infiltrating ductal carcinoma in the breast.
    Canepa M; Gambini C; Borgiani L; Pastorino A; Buccaran G; Gallo L; Storace A; Rovida S
    Pathologica; 1993; 85(1096):151-62. PubMed ID: 8395684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.